|
**Overview**: Kidney Stone Monitoring Panel**Introduction**: The Kidney Stone Monitoring Panel is a diagnostic tool designed to monitor kidney stone therapy using urine and serum samples. In India, recurrent urolithiasis requires serial monitoring of metabolic parameters (calcium, oxalate, citrate, uric acid) to assess treatment efficacy (diet, citrate supplementation, allopurinol) and prevent recurrence (~50 percent within 5 years). High morbidity from inadequate monitoring in rural/low-SES patients post-lithotripsy or on medical management, limited labs, delayed adjustment leading to repeated episodes or CKD. Per urology practices aligned with ICMR and Urological Society of India guidelines, the test employs spectrophotometry for urine calcium, oxalate, uric acid, citrate, pH, volume, and serum calcium, uric acid, phosphorus, magnesium over 1-2 days with high accuracy, valuable for therapy optimization. This diagnostic falls under renal monitoring and targets patients on stone prophylaxis or post-intervention, addressing accurate detection to guide dietary/lifestyle changes or medication. With elevated morbidity due to recurrence risk, the test supports public health efforts by enabling precise metabolic tracking and reducing stone burden. Its dual urine/serum approach ensures reliable follow-up assessment.**Other Names**: Kidney Stone Mon Pnl.**FDA Status**: FDA approved, CLIA certified for biochemistry, compliant with 2025 standards.**Historical Milestone**: Stone metabolic monitoring standard; in India, used in urolithiasis clinics.**Purpose**: The test assesses 10 parameters including urine calcium to guide kidney stone therapy monitoring, evaluate metabolic control, inform adjustment.**Test Parameters**: 1. Urine Calcium, 2. Urine Oxalate, 3. Urine Uric Acid, 4. Urine Citrate, 5. Serum Calcium, 6. Serum Uric Acid, 7. Serum Phosphorus, 8. Serum Magnesium, 9. Urine pH, 10. Urine Volume.**Pretest Condition**: Fasting 10-12 hours recommended; patients should be on stone therapy.**Specimen**: 10 mL urine (sterile container) + 3 mL serum in 1 SST, transported within specified times to maintain sample viability.**Sample Stability at Room Temperature**: Urine: 24 hours, Serum: 8 hours with proper handling to preserve analyte integrity, ensuring reliable test performance.**Sample Stability at Refrigeration**: Urine: 7 days, Serum: 7 days at 2-8 degrees Celsius, suitable for short-term storage before laboratory processing, though immediate testing is preferred.**Sample Stability at Frozen**: Urine: 6 months, Serum: 6 months at -20 degrees Celsius, allowing long-term storage for retesting, though freezing may affect some analytes.**Medical History**: Patients should provide details on current therapy, stone recurrence.**Consent**: Written informed consent is required, detailing the test's purpose, potential risks of poor control including recurrence, benefits of monitoring, and minimal discomfort from sampling.**Procedural Considerations**: The test involves sample processing using spectrophotometry by trained personnel to ensure sterile technique, avoid contamination, and interpret results within 1-2 days using provided controls. Laboratories must maintain a controlled environment, adhere to quality assurance protocols.**Factors Affecting Result Accuracy**: Delays beyond stability periods, improper storage conditions, or dietary variation can affect results. Correlation with clinical evaluation or additional testing is recommended to confirm findings.**Clinical Significance**: Improved parameters indicate therapy response; persistent abnormalities suggest adjustment, necessitating specialist input.**Specialist Consultation**: Urologists or nephrologists should be consulted for management.**Additional Supporting Tests**: Stone analysis, imaging for confirmation.**Test Limitations**: Diet-dependent; comprehensive approach required.**References**: Indian Journal of Urology 2024, Urolithiasis Studies India 2023. |
